C L Cherry

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi request reprint Biological weapons preparedness: the role of physicians
    C L Cherry
    Infectious Diseases Unit, The Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia
    Intern Med J 33:242-53. 2003
  2. ncbi request reprint Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine
    Catherine L Cherry
    Burnet Institute, Melbourne, Victoria, Australia
    J Acquir Immune Defic Syndr 38:263-7. 2005
  3. doi request reprint Age and height predict neuropathy risk in patients with HIV prescribed stavudine
    C L Cherry
    Burnet Institute, Monash University, and The Alfred Hospital, Melbourne, Australia
    Neurology 73:315-20. 2009
  4. ncbi request reprint Evaluation of a clinical screening tool for HIV-associated sensory neuropathies
    Catherine L Cherry
    Burnet Institute, Melbourne, Australia
    Neurology 65:1778-81. 2005
  5. ncbi request reprint Nucleoside analogues and HIV: the combined cost to mitochondria
    Catherine L Cherry
    Department of Medicine, Monash University and Infectious Diseases Unit, The Alfred Hospital, Melbourne, Victoira, Australia
    J Antimicrob Chemother 51:1091-3. 2003
  6. ncbi request reprint Nucleoside analogues and neuropathy in the era of HAART
    Catherine L Cherry
    Department of Infectious Diseases and Microbiology, The Alfred Hospital, Commercial Road, 3181 Prahran, Melbourne, Vic, Australia
    J Clin Virol 26:195-207. 2003
  7. ncbi request reprint Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat
    Catherine L Cherry
    Department of Infectious Diseases and Microbiology, The Alfred Hospital, Melbourne, Australia
    J Acquir Immune Defic Syndr 30:271-7. 2002
  8. ncbi request reprint Non-tropical thoraco-abdominal pyomyositis caused by group A streptococcus in an immunocompetent adult
    C Cherry
    Department of Infectious Diseases and Microbiology, The Alfred Hospital, Prahran, Victoria, Australia
    Scand J Infect Dis 33:854-6. 2001
  9. ncbi request reprint Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management
    Catherine L Cherry
    Burnet Institute for Medical Research and Public Health, GPO Box 2284, Melbourne, VIC 3001, Australia
    Sex Health 2:1-11. 2005
  10. pmc Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV
    C L Cherry
    The Alfred Hospital, Melbourne, Victoria 3004, Australia
    Neurology 74:1538-42. 2010

Collaborators

Detail Information

Publications29

  1. ncbi request reprint Biological weapons preparedness: the role of physicians
    C L Cherry
    Infectious Diseases Unit, The Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia
    Intern Med J 33:242-53. 2003
    ..The critical role of physicians as public health advocates working to prevent the use of biological weapons is also outlined...
  2. ncbi request reprint Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine
    Catherine L Cherry
    Burnet Institute, Melbourne, Victoria, Australia
    J Acquir Immune Defic Syndr 38:263-7. 2005
    ..We assessed the degree and reversibility of adipocyte apoptosis in patients with lipoatrophy before and 48 weeks after substituting abacavir or zidovudine for stavudine...
  3. doi request reprint Age and height predict neuropathy risk in patients with HIV prescribed stavudine
    C L Cherry
    Burnet Institute, Monash University, and The Alfred Hospital, Melbourne, Australia
    Neurology 73:315-20. 2009
    ..We therefore aimed to identify factors predictive of neuropathy risk before antiretroviral use...
  4. ncbi request reprint Evaluation of a clinical screening tool for HIV-associated sensory neuropathies
    Catherine L Cherry
    Burnet Institute, Melbourne, Australia
    Neurology 65:1778-81. 2005
    ..To evaluate the performance characteristics of a brief clinical neuropathy screening tool for use in sensory neuropathies complicating HIV infection...
  5. ncbi request reprint Nucleoside analogues and HIV: the combined cost to mitochondria
    Catherine L Cherry
    Department of Medicine, Monash University and Infectious Diseases Unit, The Alfred Hospital, Melbourne, Victoira, Australia
    J Antimicrob Chemother 51:1091-3. 2003
  6. ncbi request reprint Nucleoside analogues and neuropathy in the era of HAART
    Catherine L Cherry
    Department of Infectious Diseases and Microbiology, The Alfred Hospital, Commercial Road, 3181 Prahran, Melbourne, Vic, Australia
    J Clin Virol 26:195-207. 2003
    ..A clinically identical SN may also occur as a consequence of exposure to some HIV treatments. In this setting, impaired mitochondrial function is thought to play a role in the development of neurological dysfunction...
  7. ncbi request reprint Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat
    Catherine L Cherry
    Department of Infectious Diseases and Microbiology, The Alfred Hospital, Melbourne, Australia
    J Acquir Immune Defic Syndr 30:271-7. 2002
    ..A reliable and valid laboratory test to detect this is not yet available. The objective of this study was to correlate tissue mtDNA quantification in HIV-infected patients with exposure to nucleoside analogs...
  8. ncbi request reprint Non-tropical thoraco-abdominal pyomyositis caused by group A streptococcus in an immunocompetent adult
    C Cherry
    Department of Infectious Diseases and Microbiology, The Alfred Hospital, Prahran, Victoria, Australia
    Scand J Infect Dis 33:854-6. 2001
    ..This diagnosis was made when soft tissue swelling was seen on chest X-ray. Complete recovery followed drainage of the collection and short-course i.v. penicillin. The importance, diagnosis and treatment of pyomyositis are outlined...
  9. ncbi request reprint Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management
    Catherine L Cherry
    Burnet Institute for Medical Research and Public Health, GPO Box 2284, Melbourne, VIC 3001, Australia
    Sex Health 2:1-11. 2005
    ..Micronutrients may have a role, but further study is needed to clarify optimal prevention as well as monitoring strategies...
  10. pmc Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV
    C L Cherry
    The Alfred Hospital, Melbourne, Victoria 3004, Australia
    Neurology 74:1538-42. 2010
    ..Hepatitis C (HCV) coinfection is often cited as an HIV-SN risk factor, but data to support this are lacking. This collaboration aimed to examine the association between HCV serostatus and SN risk among ambulatory HIV-positive patients...
  11. ncbi request reprint Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006
    K Smyth
    Department of Medicine, Australian National University, Canberra, Australia
    HIV Med 8:367-73. 2007
    ....
  12. doi request reprint The effects of exercise training on metabolic and morphological outcomes for people living with HIV: a systematic review of randomised controlled trials
    S Fillipas
    Physiotherapy Department, The Alfred, Melbourne, Victoria, Australia Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    HIV Clin Trials 11:270-82. 2010
    ..to determine the effects of exercise on metabolic and morphological outcomes among people with HIV using a systematic search strategy of randomized, controlled trials (RCTs)...
  13. doi request reprint Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients
    Lloyd Einsiedel
    Centre for Virology, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia
    Mitochondrion 10:534-9. 2010
    ..Therapy with stavudine results in impaired mitochondrial function in CD4+PBLs that does not appear to be due to reduced mitochondrial volume or DNA content and cannot be attributed to infection with HIV...
  14. ncbi request reprint Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction
    M E Gahan
    Infectious Diseases Unit, Alfred Hospital, Department of Medicine Monash University, Prahran, Vic. 3181, Australia
    J Clin Virol 22:241-7. 2001
    ..CONCLUSIONS: From the work carried out it can be concluded that firstly, the real-time PCR assay generates consistent and reproducible results, and secondly that mtDNA can be extracted and quantified from PBMC and subcutaneous fat...
  15. ncbi request reprint Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals
    Catherine L Cherry
    Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia
    J Acquir Immune Defic Syndr 42:435-40. 2006
    ..This study examined mtDNA levels in matched samples of peripheral blood mononuclear cells (PBMCs) and subcutaneous fat from a large Australian cohort to examine treatment, clinical, and demographic associations with mtDNA depletion...
  16. doi request reprint Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction
    David J Hooker
    Centre for Virology, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia
    J Cell Mol Med 13:948-58. 2009
    ..8 for each). Together these data demonstrate that LM-PCR is a robust and reliable quantifier of apoptosis with potential for basic science and clinical investigation...
  17. doi request reprint Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk
    Catherine L Cherry
    Burnet Institute, Melbourne, Victoria, Australia
    AIDS Res Hum Retroviruses 24:117-23. 2008
    ..In addition to patient height, cytokine genotype influenced NRTI-SN risk following dNRTI exposure, suggesting inflammation contributes to NRTI-SN...
  18. ncbi request reprint Adverse effects of antiretroviral drugs on HIV-1-infected and -uninfected human monocyte-derived macrophages
    Rula Azzam
    AIDS Pathogenesis and Clinical Research Program, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia
    J Acquir Immune Defic Syndr 42:19-28. 2006
    ..We demonstrate that indinavir augments C'MP by uninfected MDMs, but not HIV-1-infected MDMs. This study provides additional understanding on the effects of commonly used antiretroviral drugs on cellular immune function...
  19. doi request reprint Physical activity uptake in patients with HIV: who does how much?
    S Fillipas
    Physiotherapy Department, The Alfred, Prahran, Vic, Australia
    Int J STD AIDS 19:514-8. 2008
    ..These findings are of concern, given the evidence-based benefits of regular physical activity. Further work is needed to identify barriers to participation and interventions that can improve uptake...
  20. ncbi request reprint Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir
    Catherine L Cherry
    Burnet Institute, Melbourne, Australia
    Curr HIV Res 6:272-5. 2008
    ..No significant adverse events occurred. Single dose DG17 is safe and best administered in a manner preventing gastric acid degradation and with low-dose ritonavir...
  21. doi request reprint A report on the effect of commencing enfuvirtide on peripheral neuropathy
    Catherine L Cherry
    Infectious Diseases Unit, Alfred Hospital, Melbourne, Australia
    AIDS Res Hum Retroviruses 24:1027-30. 2008
    ..We observed no clear evidence of neurotoxicity from enfuvirtide in this population...
  22. ncbi request reprint Ubisol-Aqua: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model
    Catherine L Cherry
    Centre for Virology, Burnet Institute, Melbourne, VIC 3001, Australia
    Curr HIV Res 8:232-9. 2010
    ..Acetyl L-carnitine (ALC) and co-enzyme Q(10) are proposed as neuropathy treatments, but evidence to support these is limited...
  23. doi request reprint The international physical activity questionnaire overestimates moderate and vigorous physical activity in HIV-infected individuals compared with accelerometry
    Soula Fillipas
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    J Assoc Nurses AIDS Care 21:173-81. 2010
    ..08-502.6 minutes) for vigorous activity. The IPAQ correlated with accelerometry, but substantial overreporting occurred. The tool may be useful in screening physical activity but should not be used to determine precise levels...
  24. pmc Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring
    Vicki L Greengrass
    Clinical Research Laboratory, Centre for Virology, Macfarlane Burnet Institute for Medical Research and Public Health, 85 Commercial Road, Melbourne, Australia
    J Clin Microbiol 47:3011-3. 2009
    ..85; n = 202). The version 3 reverse transcriptase assay shows improved sensitivity compared to the previous version...
  25. ncbi request reprint A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial
    Soula Fillipas
    Physiotherapy, Alfred Hospital, Melbourne, Vic, Australia
    Aust J Physiother 52:185-90. 2006
    ..What is the effect of a six-month, supervised, aerobic and resistance exercise program on self-efficacy in men living with human immunodeficiency virus (HIV)?..
  26. ncbi request reprint Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine
    Grace A McComsey
    Rainbow Babies and Children s Hospital bCase School of Medicine Center for AIDS Research, Cleveland, Ohio, USA
    AIDS 19:15-23. 2005
    ..As apoptosis and dysfunction of electron transport chain (ETC) activities may underlie mitochondrial toxicity, these parameters were also evaluated...
  27. ncbi request reprint HIV-associated sensory neuropathies
    Sanjay C Keswani
    AIDS 16:2105-17. 2002
  28. doi request reprint Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?
    Jacquita S Affandi
    School of Surgery and Pathology, University of Western Australia, Perth, Australia
    AIDS Res Hum Retroviruses 24:1281-4. 2008
    ..These data suggest that a simple algorithm based on patient age, height, and TNF genotype could be used to predict the individual's risk of symptomatic neuropathy prior to prescription of d4T...
  29. ncbi request reprint Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study
    Emma L Hammond
    Centre for Clinical Immunology and Biomedical Statistics, 2nd Floor, North Block, Royal Perth Hospital and Murdoch University, Australia
    J Clin Virol 27:97-110. 2003
    ..A number of international research groups have developed DNA quantitation assays in order to investigate the role of mitochondrial DNA depletion in anti-retroviral therapy-induced toxicities...